Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 289.95 USD | +0.23% |
|
-2.43% | -4.30% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 7,817 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | -4.81% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 7,068 | 6,851 | 6,710 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | -10.24% | -3.06% | -2.06% |
| P/E Ratio | 5.38x | - | -14.8x | -5.03x | 10.9x | 34.8x | 34.1x | 34.3x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | 1.12x | 1.08x | - |
| PEG | - | - | - | -0x | -0x | -0.5x | 14.93x | -48.65x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.04x | 2.97x | 2.92x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 2.75x | 2.6x | 2.51x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 17.7x | 16.1x | 15.2x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 26.5x | 23x | 20.8x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 22.7x | 21.8x | 20.6x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 4.41% | 4.58% | 4.86% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,567 | 2,635 | 2,676 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 398.6 | 426.3 | 442.3 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 266.8 | 298 | 322 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 289.95 | 289.95 | 289.95 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,762 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.77x | 2.75x | 17.73x | -.--% | 7.82B | ||
| 22.3x | 3.3x | 12.41x | 2.87% | 154B | ||
| 20.2x | 3.49x | 12.54x | 3.56% | 103B | ||
| 33.69x | 8.2x | 21.49x | 1.19% | 55.68B | ||
| 14.83x | 0.18x | 11.12x | 0.84% | 54.76B | ||
| 36.26x | 2.92x | 10.02x | 2.65% | 40.1B | ||
| 35.74x | 1.32x | 11.63x | 0.22% | 31.57B | ||
| 30.32x | 5.41x | 17.24x | -.--% | 28.64B | ||
| 39.36x | 6.81x | 24.56x | 0.27% | 23.41B | ||
| 24.13x | 3.08x | 12.56x | 1.34% | 20.6B | ||
| Average | 29.16x | 3.75x | 15.13x | 1.29% | 52.02B | |
| Weighted average by Cap. | 25.68x | 3.64x | 13.94x | 2.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















